REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,506 | -87.5% | 17,861 | -54.0% | 0.00% | – |
| Q3 2022 | $20,000 | -37.5% | 38,859 | +7.0% | 0.00% | – |
| Q2 2022 | $32,000 | -65.6% | 36,321 | -1.7% | 0.00% | – |
| Q1 2022 | $93,000 | -18.4% | 36,958 | -16.3% | 0.00% | – |
| Q4 2021 | $114,000 | -67.4% | 44,148 | -42.2% | 0.00% | – |
| Q3 2021 | $350,000 | -9.1% | 76,368 | +36.6% | 0.00% | – |
| Q2 2021 | $385,000 | -10.0% | 55,915 | -4.6% | 0.00% | – |
| Q1 2021 | $428,000 | -54.9% | 58,583 | -50.2% | 0.00% | – |
| Q4 2020 | $950,000 | -24.7% | 117,598 | -4.7% | 0.00% | – |
| Q3 2020 | $1,261,000 | +264.5% | 123,411 | +138.7% | 0.00% | – |
| Q2 2020 | $346,000 | +322.0% | 51,704 | +184.0% | 0.00% | – |
| Q1 2020 | $82,000 | -80.6% | 18,206 | -37.2% | 0.00% | – |
| Q1 2015 | $422,000 | +9.0% | 29,000 | 0.0% | 0.00% | – |
| Q4 2014 | $387,000 | +1.3% | 29,000 | 0.0% | 0.00% | – |
| Q3 2014 | $382,000 | -24.7% | 29,000 | 0.0% | 0.00% | – |
| Q2 2014 | $507,000 | +24.0% | 29,000 | 0.0% | 0.00% | – |
| Q1 2014 | $409,000 | +19.6% | 29,000 | 0.0% | 0.00% | – |
| Q4 2013 | $342,000 | +10.0% | 29,000 | 0.0% | 0.00% | – |
| Q3 2013 | $311,000 | +11.9% | 29,000 | 0.0% | 0.00% | – |
| Q2 2013 | $278,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 300 | $2,175 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |